This is a 360 degree image from the Canon Aquilion 64-slice computed tomography (CT) system installed at Northwestern Medicine Central DuPage Hospital in Winfield, Ill.  The room is large, allowing for gurney access on either side of the scanner. The two-part door to the hall also can open to allow better access.

EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3.0 surgical planning software.

Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation at Wake Radiology in Raleigh, N.C. Wake Radiology is using the platform to provide physicians access to EnvoyAI’s growing marketplace of over 53 AI engines that may be applied to their medical imaging studies. Wake Radiology selected EnvoyAI as the fastest and most comprehensive means to achieving a complete AI strategy for the diverse breadth of clinical services that it provides for patients and referring physicians.

A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission tomography/computed tomography (PET/CT) imaging on patient management of biochemically recurrent prostate cancer after initial prostate cancer treatment and negative or equivocal findings on standard-of-care imaging. The LOCATE trial is a prospective, multi-center, open-label study (NCT02680041) conducted at 15 sites in the United States. Its primary endpoint measured the percentage of men with suspected biochemical recurrence of prostate cancer following initial prior therapy whose treatment plan was changed following an 18F fluciclovine PET/CT scan.

Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for Artificial Intelligence in Diagnostic Medicine (CAIDM), is the honorary recipient of the Cornelius G. Dyke Memorial Award. The award was given by the American Society of Neuroradiology (ASNR) for Chang’s work in developing a customized deep learning system with over 97 percent accuracy in near real-time detection of hemorrhage on non-contrast computed tomography (NCCT) exam of the head.

Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery of total body irradiation (TBI). TBI is a procedure commonly used to prepare patients being treated for leukemia and multiple myeloma for a bone marrow transplant. It involves irradiation of the entire body, elevating the need for precision, accuracy and homogeneity in radiation dose delivery. The TomoTherapy platform's architecture enables efficient and effective delivery of radiation over large areas of the patient, making it a valuable part of the bone marrow transplantation conditioning regimen.

Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to undergo other preventive health services like screening for cervical cancer and osteoporosis, according to a major new study appearing online in the journal Radiology. Researchers found that even false-positive mammography findings did not reduce the likelihood of women utilizing these other preventive services.

According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when memory loss is caused by treatable issues other than Alzheimer’s Disease. The study was presented at the 2018 American Academy of Neurology Conference, April 21-27 in Los Angeles.

IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not-for-profit health system based in Louisiana.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now